Medens Pharmaceutical Private Limited
About Medens Pharmaceutical Private Limited
Data last updated:
Medens Pharmaceutical Private Limited is a private limited company based in Meerut, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24304UP2017PTC089600. Its GSTIN is 09AALCM0268N1ZW (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.5 Lakh. It is led by directors including Vinil Kumar Singh and Sanjay Kumar Joshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 22 Tejpal Singh Enclave Delhi Road, Meerut, Uttar Pradesh, India – 250002.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.09 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹2.34 Lakh (net margin 1.1%) and EBITDA of ₹5.27 Lakh (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 15% over five years.
The company has about 22 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medens Pharmaceutical Private Limited's registered office is in Meerut, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressC – 22 Tejpal Singh Enclave Delhi Road, Meerut, Uttar Pradesh, India – 250002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medens Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medens Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Medens Pharmaceutical Private Limited, buy the company report.
Financials of Medens Pharmaceutical Private Limited
FY 2025 filings availableMedens Pharmaceutical Private Limited reported revenue of ₹2.09 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 7% growth in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.27 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medens Pharmaceutical Private Limited, buy the company report.
Board of directors of Medens Pharmaceutical Private Limited
Medens Pharmaceutical has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinil Kumar Singh | Director | 27 Oct 2020 | 6 Years 0 Months | Current |
| Sanjay Kumar Joshi | Director | 16 Aug 2019 | 7 Years 2 Months | Current |
| Satish Pathak | Director | 16 Aug 2019 | 7 Years 2 Months | Current |
Peer comparison
Medens Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Community Crafts Exports Private Limited | ₹2.09 Cr (FY 2016) | -14.0% | Uttar Pradesh, India | |||
| Motorhunk Private Limited | ₹2.09 Cr (FY 2024) | -18.0% | Ghaziabad, Uttar Pradesh, India | |||
| Orgabliss Herbs and Foods Private Limited | ₹2.09 Cr (FY 2017) | New Delhi, Delhi, India | ||||
| Ensign Apparels Private Limited | ₹2.09 Cr (FY 2025) | 6.0% | Jaipur, Rajasthan, India | |||
| Shri Balaji Tractors and Farm Equipment Private Limited | ₹2.09 Cr (FY 2022) | 18.0% | Pune, Maharashtra, India | |||
| Medens Pharmaceutical Private Limitedthis company | ₹2.09 Cr (FY 2025) | ₹2.34 Lakh | 1.1% | 7.0% | 22 | Meerut, Uttar Pradesh, India |
| Sigmatech Services Private Limited | ₹2.09 Cr (FY 2016) | 497.0% | Kolkata, West Bengal, India | |||
| Apex Automobiles Private Limited | ₹2.09 Cr (FY 2019) | -4.0% | Delhi, India | |||
| Project VM Nutrition Private Limited | ₹2.09 Cr (FY 2025) | -19.0% | Delhi, India | |||
| Edakkara Agro Producer Company Limited | ₹2.09 Cr (FY 2025) | 69.0% | Edakkara, Kerala, India | |||
| Sealine Foreign Merchandise Private Limited | ₹2.09 Cr (FY 2015) | 1452.0% | Kochi, Kerala, India |
To see the full peer comparison of Medens Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Sep 2020 | 100394803 | Others | ₹9.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medens Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medens Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medens Pharmaceutical Private Limited has a workforce of 22 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
GST
Medens Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AALCM0268N1ZW | Uttar Pradesh | Active | 19 Sep 2018 |
To see the full GST registrations and return filing status of Medens Pharmaceutical Private Limited, buy the company report.
Recent activity
Medens Pharmaceutical Private Limited has 8 board changes on record since 2017: 3 appointments and 5 cessations. The latest: Vinil Kumar Singh was appointed as Director on 27 Oct 2020.
Frequently asked questions
Medens Pharmaceutical is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 February 2017 (9+ years old) and is registered under CIN U24304UP2017PTC089600.
Medens Pharmaceutical has 3 current directors:
- Vinil Kumar Singh - Director
- Sanjay Kumar Joshi - Director
- Satish Pathak - Director
The latest financial statements of Medens Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Medens Pharmaceutical is 09AALCM0268N1ZW, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Medens Pharmaceutical is U24304UP2017PTC089600. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medens Pharmaceutical was incorporated on 02 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Medens Pharmaceutical by revenue are Community Crafts Exports Private Limited, Motorhunk Private Limited, Orgabliss Herbs and Foods Private Limited, Ensign Apparels Private Limited, Shri Balaji Tractors and Farm Equipment Private Limited and 5 more, all in the same principal business activity (retail trading).
Vinil Kumar Singh was appointed as Director on 27 Oct 2020. Ritu Saxena ceased to be Director on 26 Aug 2019. Sanjeev Saxena ceased to be Director on 26 Aug 2019. Medens Pharmaceutical has 8 board changes on record in total.
The registered office of Medens Pharmaceutical is at C – 22 Tejpal Singh Enclave Delhi Road, Meerut, Uttar Pradesh, India – 250002.
Medens Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Medens Pharmaceutical has open charges of ₹9.5 Lakh and no satisfied charges on record as per latest MCA filings.